Katsunori Masaki, Koichi Fukunaga, Kazuyo Moro, Sotaro Uemura, Mai Yamagishi, Makoto Suematsu, Yasuaki Kabe, Toru Kikawada, Yasutomo Araki, Jun Miyata, Misato Irie, Satoshi Koga, Masako Matsusaka, Rie Baba, Takashi Kamatani, Yoshitaka Shirasaki, Momoko Kurihara, Kotaro Sasahara, Hiroki Kabata
Journal: Cell reports 2023;42(6):112610
PMID: 37294636
Group 2 innate lymphoid cells (ILC2s) produce large amounts of type 2 cytokines including interleukin-5 (IL-5) and IL-13 in response to various stimuli, causing allergic and eosinophilic diseases. However, the cell-intrinsic regulatory mechanisms of human ILC2s remain unclear. Here, we analyze human ILC2s derived from different tissues and pathological conditions and identify ANXA1, encoding annexin A1, as a commonly highly expressed gene in non-activated ILC2s. The expression of ANXA1 decreases when ILC2s activate, but it increases autonomously as the activation subsides. Lentiviral vector-based gene transfer experiments show that ANXA1 suppresses the activation of human ILC2s. Mechanistically, ANXA1 regulates the expression of the metallothionein family genes, including MT2A, which modulate intracellular zinc homeostasis. Furthermore, increased intracellular zinc levels play an essential role in the activation of human ILC2s by promoting the mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) pathways and GATA3 expression. Thus, the ANXA1/MT2A/zinc pathway is identified as a cell-intrinsic metalloregulatory mechanism for human ILC2s.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Full Text Sources:
Miscellaneous:
Molecular Biology Databases:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.